by Hydroxyapatite is a naturally occurring mineral form of calcium apatite, with the chemical formula Ca10(PO4)6(OH)2. It is the major component of dental enamel and bones. Hydroxyapatite has a wide range of medical applications such as bone grafts due to its superior osteoconductivity and biocompatibility properties. Hydroxyapatite bone grafts enable new bone growth resulting in less painful fusion and faster healing time compared to autograft and allograft procedures.
The Global Hydroxyapatite Market is estimated to be valued at US$ 2761.23 Mn in 2024 and is expected to exhibit a CAGR of 6.5% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the Hydroxyapatite market are West Pharmaceutical Services Inc., Berry Global Inc., Sartorius AG, Corning Inc., Gerresheimer AG, SCHOTT AG, Stevanato Group, AptarGroup Inc., SGD Pharma, Ompi – Stevanato Group, DWK Life Sciences, Nipro Corporation, Nolato AB, Terumo Corporation, Qosina Corp. The leading players are focusing on new product launches and partnerships to expand their shares in the global market. For instance, in 2022 West Pharmaceutical Services Inc. launched Hextend-HA, a novel premixed hydroxyethyl starch solute and calcium hydroxyapatite delivery system for fluid resuscitation.
The Hydroxyapatite Market Demand for bone grafts is growing rapidly due to the increasing prevalence of osteoporosis and orthopedic surgeries. Hydroxyapatite bone grafts are widely used in orthopedic, dental and maxillofacial surgeries worldwide. Moreover, rapid growth in geriatric population who are more prone to bone disorders like osteoporosis is a major factor fueling the hydroxyapatite market growth.
The key players are expanding their businesses globally especially in Asian countries to tap the high growth opportunities. For instance, in 2022 Sartorius AG opened a new production site for cell culture media in China to strengthen its market position and better serve the fast-growing biopharma industry in Asia.
Market key trends
Nanotechnology is playing a vital role in enhancing the biomedical applications of hydroxyapatite. Nanohydroxyapatite (nHA) has improved bioactivity, biocompatibility and osteogenic properties compared to bulk HA materials. nHA acts as an osteoinductive biomaterial scaffold that promotes new bone formation. The rising adoption of nHA in various bone graft substitutes and implants is a major trend in the Hydroxyapatite Market.
Porter’s Analysis
Threat of new entrants: The threat is moderate due to the technical expertise required and established distribution channels of existing players.
Bargaining power of buyers: The bargaining power is high due to the availability of substitute products.
Bargaining power of suppliers: The bargaining power of suppliers is moderate due to the availability of substitute raw materials.
Threat of new substitutes: The threat is high due to the availability of alternative products that can be used for various applications of hydroxyapatite.
Competitive rivalry: Competition is intense due to the presence of many global and domestic players.
Geographical Regions
North America holds the largest share of the hydroxyapatite market due to the increasing demand from dental and orthopedic applications. According to various studies, around 150 million Americans suffer from tooth loss and dental diseases. This has boosted the demand for hydroxyapatite in dental applications.
The Asia Pacific region is expected to grow at the fastest rate during the forecast period. Factors such as the increasing spending capacity, growing geriatric population, and rising healthcare awareness are driving the demand for orthopedic and dental treatments, which in turn is fueling the growth of the hydroxyapatite market in the region. Countries such as India, China, and Japan are projected to offer ample growth opportunities for market players.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
